Penumbra, Inc. (PEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:15AM EDT. Market open.
| Previous close | 202.04 |
| Open | 201.11 |
| Bid | 199.20 x 800 |
| Ask | 200.04 x 800 |
| Day's range | 199.10 - 201.97 |
| 52-week range | 180.93 - 348.67 |
| Volume | |
| Avg. volume | 349,638 |
| Market cap | 7.773B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | 86.44 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
- Zacks
Here's Why You Should Retain Penumbra (PEN) Stock for Now
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
- GuruFocus.com
Insider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
Penumbra Inc (NYSE:PEN), a global healthcare company focused on innovative therapies, has seen a recent insider transaction according to the latest SEC filings.
© 2024 Yahoo. All rights reserved.